Cargando…
Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study
BACKGROUND: The primary objective of this study was to evaluate long-term (24-week) safety of eszopiclone in elderly and nonelderly Japanese patients with chronic insomnia. The secondary objectives were to evaluate short-term (4-week) efficacy and to assess for rebound insomnia or dependence after l...
Autores principales: | Uchimura, Naohisa, Kamijo, Atsushi, Takase, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430596/ https://www.ncbi.nlm.nih.gov/pubmed/22731653 http://dx.doi.org/10.1186/1744-859X-11-15 |
Ejemplares similares
-
Eszopiclone for late-life insomnia
por: McCrae, Christina S, et al.
Publicado: (2007) -
Eszopiclone: its use in the treatment of insomnia
por: Monti, Jaime M, et al.
Publicado: (2007) -
Eszopiclone versus zopiclone in the treatment of insomnia
por: Pinto, Luciano Ribeiro, et al.
Publicado: (2016) -
Management of insomnia in elderly patients using eszopiclone
por: Kirkwood, Cynthia, et al.
Publicado: (2010) -
Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study
por: Inoue, Yuichi, et al.
Publicado: (2021)